Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Tiranova SA"'
Autor:
Tiranova Sa, EV Karyagina, Gritsaev Sv, ZhV Chubukina, Irina Martynkevich, SS Bessmeltsev, II Kostroma, Transfusiology, ya Sovetskaya str., Saint Petersburg, Russian Federation, AA Zhernyakova, AV Chechetkin, IM Zapreeva
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 3, Pp 282-288 (2019)
Background. In multiple myeloma (MM) treatment a single autologous hematopoietic stem cell transplantation (auto-HSCT) is preceded by conditioning regimens aimed at intensifying cytoreductive effect. In the course of ongoing search for combined condi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c138cb066f9940bf52e07b14a5462cf8
https://doaj.org/article/bfaed30791374981b68122051e37b0de
https://doaj.org/article/bfaed30791374981b68122051e37b0de
Autor:
Gritsaev Sv, SS Bessmeltsev, Transfusiology, ya Sovetskaya str., Saint Petersburg, Russian Federation, Tiranova Sa, ZhV Chubukina, II Kostroma, AV Chechetkin, IM Zapreeva, AA Zhernyakova, NYu Semenova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 1, Pp 32-36 (2018)
Background. The success of autologous hematopoietic stem cell transplantation (auto-HSCT) depends on the speed of transplant engraftment which in turn is affected by the count of harvested and infused hematopoietic stem cells (HSC). Aim. To identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::426b467aede5b7fced2a783f8e66a2fb
http://bloodjournal.ru/wp-content/uploads/2018/12/4-1.pdf
http://bloodjournal.ru/wp-content/uploads/2018/12/4-1.pdf
Autor:
LB Polushkina, Irina Martynkevich, Tiranova Sa, I. Zotova, NA Potikhonova, VA Shuvaev, R. Golovchenko, VYu Udal’eva, M. Ivanova, Kudrat Abdulkadyrov, EV Kleina, E. V. Petrova, S.A. Kudryashova, LS Martynenko, Fominykh, NV Shakhvorostova, MN Zenina, NYu Tsybakova, DI Shikhbabaeva
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 1, Pp 54-60 (2016)
Background & Aims. Interpretation of key aspects of pathogenesis of chronic myeloid leukemia (CML) and development and introduction of target therapy have changed the prognosis of this once fatal disease dramatically. Results of numerous clinical tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e04a87c525251fc34ed4d0488beb8a07
http://bloodjournal.ru/en/chronic-myeloid-leukemia-long-term-experience-of-target-therapy/
http://bloodjournal.ru/en/chronic-myeloid-leukemia-long-term-experience-of-target-therapy/
Autor:
IM Zapreeva, NA Potikhonova, EV Litvinskaya, Tiranova Sa, SV Gritsaev, K M Abdulkadyrov, AA Kuzyaeva, II Kostroma, LV Stel’mashenko, IS Martynkevich
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 1, Pp 48-53 (2016)
Aim. The aim of this paper is to evaluate the effectiveness of low dose cytarabine (Ara-C) combined with cladribine for the treatment of relapsed or refractory acute myeloid leukemia (AML) and to determine clinical and lab factors associated with res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae23792aa270637ae708cb90cbebba05
http://bloodjournal.ru/en/low-dose-cytarabine-and-cladribine-for-treatment-of-relapsed-or-refractory-acute-myeloid-leukemia-clinical-experience/
http://bloodjournal.ru/en/low-dose-cytarabine-and-cladribine-for-treatment-of-relapsed-or-refractory-acute-myeloid-leukemia-clinical-experience/
Autor:
Tiranova Sa, LYu Zhiguleva, MN Zenina, S S Bessmeltsev, N A Romanenko, K M Abdulkadyrov, AE Romanenko, NA Potikhonova
Publikováno v:
Clinical oncohematology. 8:368-378
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd46311945b98504240e17ab763d247f
https://doi.org/10.21320/2500-2139-2015-8-4-368-378
https://doi.org/10.21320/2500-2139-2015-8-4-368-378
Autor:
Tiranova Sa, Yu S Drizhun, Gritsaev Sv, S.P. Svitina, Irina Martynkevich, Zh V Chubukina, SS Bessmeltsev, II Kostroma, S.I. Kapustin, Zh.Yu. Sidorova
Publikováno v:
Terapevticheskii arkhiv. 88(7)
to investigate the methylation status of the SOX7 and p15NK4b genes and Wnt signaling pathway antagonists in patients with acute myeloid leukemia (AML) in order to assess the association of the rate of aberrant methylation (AM) with the morphological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8213078815f25b6d2d6d96662162b78c
https://pubmed.ncbi.nlm.nih.gov/27459612
https://pubmed.ncbi.nlm.nih.gov/27459612
Autor:
II Kostroma, Tiranova Sa, Zh V Chubukina, A V Shmidt, Balashova Va, N.Yu. Semenova, Gritsaev Sv, I M Zapreev, Irina Martynkevich, AV Chechetkin
Publikováno v:
Terapevticheskii arkhiv. 88(7)
Secondary myeloid neoplasia may be a complication of intensive cytostatic therapy. The most common types of secondary neoplasias are acute myeloid leukemia and myelodysplastic syndrome. The development of secondary atypical chronic myeloid leukemia (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f61426c7024c7cd0b1905acf14ef68f6
https://pubmed.ncbi.nlm.nih.gov/27459623
https://pubmed.ncbi.nlm.nih.gov/27459623
Autor:
K M Abdulkadyrov, MN Zenina, Potikhonova Na, Balashova Va, Gritsaev Sv, G M Ryadnova, Tiranova Sa, I I Kostroma, Irina Martynkevich, Zh V Chubukina
Publikováno v:
Terapevticheskii arkhiv. 87(7)
This rare type of acute leukemia, blast cells of which express myeloid and/or lymphoid markers, is mainly diagnosed using flow cytometric findings. The paper describes a clinical case of mixed-phenotype acute leukemia, in which B-cell lymphoid antige
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb71f290707f86702d23a401f78de0e8
https://pubmed.ncbi.nlm.nih.gov/26390732
https://pubmed.ncbi.nlm.nih.gov/26390732
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.